$2.12
0.178.72%
Last update: Nov 11, 4:00 PM
Cerus Corp
CERSNASDAQ
Cerus rose 28.5% from $1.65 to $2.12, ahead of the S&P 500's +9.8%. Its worst day was Jul 31 (−25.6%), and its low came Nov 18 at $1.49.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Cerus closed at its lowest level of the year, 9.7% below where the year started.
−2.6% · S&P 500 −0.8%
Cerus shares rose 13.1%, while the S&P 500 rose 0.1%.
+13.1% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S.
+13.8% · S&P 500 +0.2%
EPS of $-0.01 beat the $-0.01 estimate on $57.8M revenue (est. $59.3M); FY revenue guidance of $224.0M–$228.0M against the $242.1M consensus.
−15.8% · S&P 500 −0.9%
EPS of $-0.01 beat the $-0.03 estimate on $53.7M revenue (est. $51.2M); FY revenue guidance of $227.0M–$231.0M against the $233.9M consensus.
+34.0%, the year's best day, on 25M shares, the year's heaviest volume · S&P 500 +0.3%
Cerus closed at its highest level of the year, 98.8% above where the year started.
+3.8% · S&P 500 +0.9%
EPS of $-0.01 beat the $-0.01 estimate on $57.4M revenue (est. $58.9M); FY revenue guidance of $229.0M–$231.0M against the $238.1M consensus.
−25.6%, the year's worst day · S&P 500 +0.7%
EPS of $0.00 beat the $-0.01 estimate on $57.7M revenue (est. $61.1M); FY revenue guidance of $229.0M–$231.0M against the $249.1M consensus.
−0.8% · S&P 500 +0.3%
Where it ended: a close of $2.12 on Nov 11, 2026. Up next: Q4 2026 earnings on Mar 1, 2027 (EPS est. $-0.01, revenue est. $62.7M).
Nothing in the past 12 months.
All CERS dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CERS and SPY from Benzinga historical bars. Not investment advice.
